---
title: "Estimating Covariance Between Age at Onset and Disorder Liability in Censored Samples"
id: "medrxiv-0-age-at-onset-and-liability-to-disorder-estimating-covariances-in-censored"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-age-at-onset-and-liability-to-disorder-estimating-covariances-in-censored"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1?rss=1"
published_at: "2026-08-06T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Estimating Covariance Between Age at Onset and Disorder Liability in Censored Samples
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-age-at-onset-and-liability-to-disorder-estimating-covariances-in-censored
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1?rss=1)
- **Published At:** 2026-08-06T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Studies of binary disorder status are often biased by **censoring**: individuals currently unaffected may develop the disorder later, distorting estimates of resemblance between relatives. - The authors develop a model linking individual **liability** to disorder and **age at onset** to estimate their covariance in samples with censoring. - The model is implemented as a **mixture distribution** designed for pairs of relatives, using differences in concordant and discordant relative pairs to identify covariance when individual-level onset data are incomplete. - The approach addresses a limitation of non-related samples, which lack variation in family resemblance needed to estimate the liability–onset covariance. - The method contrasts conceptually with **Cox Proportional Hazards**, which treats liability and onset timing along a single dimension; the new model treats them as associated but distinct. - The method was applied to **cannabis use** data from the Virginia Twin Study of Adolescent Behavioral Development. - In that application the estimated association between **age at onset** and liability was negative (−0.212) with 95% confidence intervals −0.263 to −0.152, indicating earlier onset associated with higher liability. - Data produced in the study are available on reasonable request to the authors via the Virginia Institute for Psychiatric and Behavioral Genetics repository. - Ethical oversight was provided by the Ethics committee/IRB of Virginia Commonwealth University (MODCR00000036/ HM20025077). - The study was funded by NIDA/NIH (5U01DA051037-07).
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=Evw7fWSJ4oz5Ysfdu3VbPHr4eCdoMJdWYsgKbgwzbc8-1786057982.2334983-1.2.1.1-DD_QppDylNjMLnqPKZRxNu7zdQc8L4H6jNKz9Z9RSko) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Age at Onset and Liability to Disorder: Estimating Covariances in Censored Populations [ View ORCID Profile](http://orcid.org/0000-0003-4887-659X)Michael C Neale, [ View ORCID Profile](http://orcid.org/0000-0001-7489-2214)Hermine H. Maes, [ View ORCID Profile](http://orcid.org/0009-0002-6907-0640)Lanie K. Mullins, [ View ORCID Profile](http://orcid.org/0000-0002-9396-2860)Madhurbain Singh, [ View ORCID Profile](http://orcid.org/0000-0003-4466-248X)Jared Balbona, [ View ORCID Profile](http://orcid.org/0009-0000-4703-1937)Robert M. Kirkpatrick, [ View ORCID Profile](http://orcid.org/0000-0002-3339-9279)Timothy R. Brick, [ View ORCID Profile](http://orcid.org/0000-0002-3651-6709)Michael D. Hunter, [ View ORCID Profile](http://orcid.org/0000-0003-2117-8548)Steven M. Boker, [ View ORCID Profile](http://orcid.org/0000-0002-0952-5052)Luis Castro-de-Araujo, [ View ORCID Profile](http://orcid.org/0000-0003-4164-9335)Andrew J. Schork, [ View ORCID Profile](http://orcid.org/0000-0002-4452-0732)Morten Dybdahl Krebs, [ View ORCID Profile](http://orcid.org/0000-0003-3036-545X)Joel A. Mefford doi: https://doi.org/10.64898/2026.08.04.26359043 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Michael C Neale 1 Virginia Commonwealth University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BC%2BNeale%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Neale%20MC&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BC%2BNeale%2B) * [ORCID record for Michael C Neale](http://orcid.org/0000-0003-4887-659X "Open in new tab") * For correspondence: neale@vcu.edu Hermine H. Maes 2 Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, USA; Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, Richmond, Virginia, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hermine%2BH.%2BMaes%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Maes%20HH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHermine%2BH.%2BMaes%2B) * [ORCID record for Hermine H. Maes](http://orcid.org/0000-0001-7489-2214 "Open in new tab") Lanie K. Mullins 2 Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, USA; Department of Cellular, Molecular and Genetic Medicine, Virginia Commonwealth University, Richmond, Virginia, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lanie%2BK.%2BMullins%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mullins%20LK&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALanie%2BK.%2BMullins%2B) * [ORCID record for Lanie K. Mullins](http://orcid.org/0009-0002-6907-0640 "Open in new tab") Madhurbain Singh 3 Social, Genetic and Developmental Psychiatry Centre, King's College, London, UK; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Madhurbain%2BSingh%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Singh%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMadhurbain%2BSingh%2B) * [ORCID record for Madhurbain Singh](http://orcid.org/0000-0002-9396-2860 "Open in new tab") Jared Balbona 4 Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jared%2BBalbona%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Balbona%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJared%2BBalbona%2B) * [ORCID record for Jared Balbona](http://orcid.org/0000-0003-4466-248X "Open in new tab") Robert M. Kirkpatrick 4 Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Robert%2BM.%2BKirkpatrick%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Kirkpatrick%20RM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ARobert%2BM.%2BKirkpatrick%2B) * [ORCID record for Robert M. Kirkpatrick](http://orcid.org/0009-0000-4703-1937 "Open in new tab") Timothy R. Brick 5 Department of Human Development and Family Studies, The Pennsylvania State University, University Park, PA 16802; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Timothy%2BR.%2BBrick%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Brick%20TR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ATimothy%2BR.%2BBrick%2B) * [ORCID record for Timothy R. Brick](http://orcid.org/0000-0002-3339-9279 "Open in new tab") Michael D. Hunter 5 Department of Human Development and Family Studies, The Pennsylvania State University, University Park, PA 16802; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BD.%2BHunter%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hunter%20MD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BD.%2BHunter%2B) * [ORCID record for Michael D. Hunter](http://orcid.org/0000-0002-3651-6709 "Open in new tab") Steven M. Boker 6 Department of Psychology, University of Virginia, Charlottesville, Virginia, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Steven%2BM.%2BBoker%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Boker%20SM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASteven%2BM.%2BBoker%2B) * [ORCID record for Steven M. Boker](http://orcid.org/0000-0003-2117-8548 "Open in new tab") Luis Castro-de-Araujo 4 Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, Virginia, USA; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Luis%2BCastro-de-Araujo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Castro-de-Araujo%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALuis%2BCastro-de-Araujo%2B) * [ORCID record for Luis Castro-de-Araujo](http://orcid.org/0000-0002-0952-5052 "Open in new tab") Andrew J. Schork 7 Institute for Biological Psychiatry, Copenhagen University Hospital Amager-Hvidovre, Copenhagen, Denmark; Department of Neuroscience, Copenhagen University, Copenhagen, Denmark; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andrew%2BJ.%2BSchork%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Schork%20AJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAndrew%2BJ.%2BSchork%2B) * [ORCID record for Andrew J. Schork](http://orcid.org/0000-0003-4164-9335 "Open in new tab") Morten Dybdahl Krebs 8 Institute for Biological Psychiatry, Copenhagen University Hospital Amager-Hvidovre, Copenhagen, Denmark * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Morten%2BDybdahl%2BKrebs%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Krebs%20MD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMorten%2BDybdahl%2BKrebs%2B) * [ORCID record for Morten Dybdahl Krebs](http://orcid.org/0000-0002-4452-0732 "Open in new tab") Joel A. Mefford 8 Institute for Biological Psychiatry, Copenhagen University Hospital Amager-Hvidovre, Copenhagen, Denmark * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Joel%2BA.%2BMefford%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mefford%20JA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJoel%2BA.%2BMefford%2B) * [ORCID record for Joel A. Mefford](http://orcid.org/0000-0003-3036-545X "Open in new tab") * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1273613/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1273613/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1273613/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1273613/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1273613/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Studies of resemblance for disorders and other traits measured at the binary (yes/no) level between relatives frequently contain individuals who are currently in the negative category but who will become positive in future. For example, a 10-year-old may develop depression in the future, but is as yet unaffected. Such censoring can substantially bias estimates of correlation between relatives. To overcome this problem we develop a model for the association between liability to a disorder, and its age at onset. The model is designed for data from pairs of relatives to enable estimation of the correlation between an individuals' liability to disorder and their age at onset. Usually, such information is not available at the individual level, because age at onset is uniquely available when onset has occurred. Lacking variation in disorder status, data from non-related persons cannot estimate the covariance between liability and age at onset. Data from relatives can resolve this issue when there is a correlation in liability between the relatives, because different age at onset distributions would be expected in concordant vs. discordant pairs of relatives. Greater severity and worse outcomes are often observed among those with earlier onset, so a correlation between disorder liability and age at onset seems likely in many cases. In this article we present the basic theory of the model, implemented as a mixture distribution, and an application to cannabis use in a Virginia Twin Study of Adolescent Behavioral Development. A negative association of (-.212) between age at onset an liability was found, with confidence intervals of -.263 to -.152, which do not cross zero. The method contrasts with Cox Proportional Hazards, in which disorder liability and onset timing are treated as a single dimension. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics committee/IRB of Virginia Commonwealth University gave ethical approval for this work, per records MODCR00000036/ HM20025077. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Funder Information Declared NIDA/NIH, 5U01DA051037-07 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC 4.0 International license](http://creativecommons.org/licenses/by-nc/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2025.11.28.25340407v2 "Rising resistance to linezolid among critically ill patients calls for model-informed precision dosing in the empirical setting") Posted August 06, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/06/2026.08.04.26359043.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.04.26359043v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/06/2026.08.04.26359043.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Age at Onset and Liability to Disorder: Estimating Covariances in Censored Populations Michael C Neale, Hermine H. Maes, Lanie K. Mullins, Madhurbain Singh, Jared Balbona, Robert M. Kirkpatrick, Timothy R. Brick, Michael D. Hunter, Steven M. Boker, Luis Castro-de-Araujo, Andrew J. Schork, Morten Dybdahl Krebs, Joel A. Mefford medRxiv 2026.08.04.26359043; doi: https://doi.org/10.64898/2026.08.04.26359043 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.04.26359043v1%26text%3DAge%2520at%2520Onset%2520and%2520Liability%2520to%2520Disorder%253A%2520Estimating%2520Covariances%2520in%2520Censored%2520Populations "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.04.26359043v1%26t%3DAge%2520at%2520Onset%2520and%2520Liability%2520to%2520Disorder%253A%2520Estimating%2520Covariances%2520in%2520Censored%2520Populations "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.04.26359043v1%26title%3DAge%2520at%2520Onset%2520and%2520Liability%2520to%2520Disorder%253A%2520Estimating%2520Covariances%2520in%2520Censored%2520Populations%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.04.26359043v1%26title%3DAge%2520at%2520Onset%2520and%2520Liability%2520to%2520Disorder%253A%2520Estimating%2520Covariances%2520in%2520Censored%2520Populations "Share on
## Related Clinical Research

- [Fitspiration vs Thinspiration: Effects on Body and Functionality Appreciation in Young Chinese Wom](https://medichelpline.com/clinical-feed/plos-one-9-rethinking-fitspiration-in-social-media-experimental-insights-from-young.md)
- [Kurort Health Walking in a Forest: Short-Term Physiological and Psychological Effects](https://medichelpline.com/clinical-feed/plos-one-3-physiological-and-psychological-outcomes-of-a-community-based-kurort-health.md)
- [Saliva-based nanopore sequencing panel for pharmacogenomic screening in drug-resistant tuberculosis](https://medichelpline.com/clinical-feed/medrxiv-5-nanopore-sequencing-panel-for-saliva-based-host-pharmacogenomic-screening-in.md)
- [Flood Exposure and Depressive Symptoms in Indonesia: Bayesian Multilevel Analysis of Community Res](https://medichelpline.com/clinical-feed/medrxiv-5-from-structural-resources-to-latent-protective-capacity-a-bayesian-multilevel.md)
- [MRSA in Vietnamese NICUs: Epidemiology, Treatment, and Control Strategies for Neonates](https://medichelpline.com/clinical-feed/pubmed-42687663.md) (DOI: 10.1080/14787210.2026.2726969)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.